17 results match your criteria: "9.Baby - Family and Fertility Center[Affiliation]"
Hum Reprod Open
April 2023
Instituto Valenciano de Infertilidad (IVI-RMA), Madrid, Spain.
Although a wealth of data has been published regarding fertility preservation (FP) in women with malignant diseases who receive gonadotoxic treatment, the role of FP in non-malignant conditions has been studied to a much lesser extent. These include benign haematological, autoimmune, and genetic disorders, as well as a multitude of benign gynaecological conditions (BGCs) that may compromise ovarian reserve and/or reproductive potential due to pathogenic mechanisms or as a result of medical or surgical treatments. Alongside accumulating data that document the reproductive potential of cryopreserved oocytes and ovarian tissue, there is potential interest in FP for women with BGCs at risk of infertility; however, there are currently insufficient data about FP in women with BGCs to develop guidelines for clinical practice.
View Article and Find Full Text PDFReprod Biomed Online
June 2023
Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
For more than two decades, the European IVF-Monitoring Consortium has collected data on IVF in Europe with the aim of monitoring the quality and safety of assisted reproductive technology (ART) treatments, to ensure the highest performance with the lowest risk for patients and their offspring. Likewise, the Society for Assisted Reproductive Technology in the USA and the Australia/New Zealand Assisted Reproduction Database collect, process and publish data in their regions. The better the legal framework for ART surveillance, the more complete and reliable are the datasets.
View Article and Find Full Text PDFJ Assist Reprod Genet
September 2022
Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101-1090, Brussels, Belgium.
Purpose: Does cell loss (CL) after vitrification and warming (V/W) of day 3 embryos have an impact on live birth rate (LBR) and neonatal outcomes?
Method: This retrospective analysis includes cleavage stage day 3 embryos vitrified/warmed between 2011 and 2018. Only single vitrified/warmed embryo transfers were included. Pre-implantation genetic screening, oocyte donation, and age banking were excluded from the analysis.
Mol Hum Reprod
July 2021
9.baby Family and Fertility Center, Bologna, Italy.
The sperm is essential for reconstitution of embryonic diploidy and highly specialized developmental functions. Immediately after gamete fusion, the sperm-borne PLC-zeta triggers activation, generating intracellular free Ca2+ oscillations. Mutations in the PLC-zeta encoding gene are associated with the absence of this factor in mature sperm and inability to achieve fertilization.
View Article and Find Full Text PDFHum Reprod Update
August 2021
CARE Fertility Group, Northampton, UK.
Background: IVF for the treatment of infertility offers unique opportunities to observe human preimplantation development. Progress in time-lapse technology (TLT) and preimplantation genetic testing (PGT) has greatly expanded our knowledge of developmental patterns leading to a healthy pregnancy or developmental failure. These technologies have also revealed unsuspected plastic properties of the preimplantation embryo, at macromolecular, cellular and multicellular levels.
View Article and Find Full Text PDFJ Assist Reprod Genet
July 2021
Bedford Research Foundation, Bedford, MA, USA.
Nucleolus precursor bodies (NPB) are aggregations of intrapronuclear material observed in the pronuclei of fertilized human eggs. They derive from and evolve into nucleoli of the growing oocyte and the early embryo, respectively. Decades-old observations suggest that the patterns of their distribution represent a morphological marker of embryo developmental competence.
View Article and Find Full Text PDFJ Assist Reprod Genet
July 2021
9.baby Family and Fertility Center, Via Dante, 15, 40125, Bologna, Italy.
Purpose: To study embryo morphokinetics in relation to release in spent media of molecules with possible roles in development and implantation (miR-20a, miR-30c, and sHLA-G).
Methods: Data were obtained from embryos generated in standard IVF and ICSI cycles. The Eeva system was used for embryo assessment, based on early morphokinetic parameters and producing a score (1-5, best-worst) corresponding to higher/medium/lower chances of development to blastocyst.
J Assist Reprod Genet
May 2021
Reproductive Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Purpose: To explore how the assisted reproductive technology (ART) laboratories can be optimized and standardized to enhance embryo culture and selection, to bridge the gap between standard practice and the new concept of shortening time to healthy singleton birth.
Methods: A Delphi consensus was conducted (January to July 2018) to assess how the ART laboratory could be optimized, in conjunction with existing guidelines, to reduce the time to a healthy singleton birth. Eight experts plus the coordinator discussed and refined statements proposed by the coordinator.
Reprod Biomed Online
March 2021
Department of Biology and Biotechnology 'Lazzaro Spallanzani', University of Pavia, Via Ferrata, 9 27100, Italy; Centre for Health Technology, University of Pavia, Pavia, Italy. Electronic address:
Research Question: Can artificial intelligence and advanced image analysis extract and harness novel information derived from cytoplasmic movements of the early human embryo to predict development to blastocyst?
Design: In a proof-of-principle study, 230 human preimplantation embryos were retrospectively assessed using an artificial neural network. After intracytoplasmic sperm injection, embryos underwent time-lapse monitoring for 44 h. For comparison, standard embryo assessment of each embryo by a single embryologist was carried out to predict development to blastocyst stage based on a single picture frame taken at 42 h of development.
Hum Reprod Open
May 2020
Centre for Medical Genetics, Universitair Ziekenhuis Brussel, Brussels, Belgium.
J Assist Reprod Genet
July 2020
9.baby - Family and Fertility Center, via Dante 15, 40125, Bologna, Italy.
Purpose: To explore the possible influence of sperm quality, as assessed by prewash total sperm count (TSC), on cumulative success rates in assisted reproduction cycles.
Methods: Retrospective study carried out in private IVF centre. Seven hundred sixty-five couples undergoing complete ICSI cycles, i.
Hum Reprod Open
March 2020
9.baby Family and Fertility Center, Bologna, Italy.
J Assist Reprod Genet
October 2019
9.Baby - Family and Fertility Center, Via Dante 15, 40125, Bologna, Italy.
Purpose: In this study, we tested the hypothesis that, in PGT-A cycles, decreased semen quality is associated with increased rates of mosaic blastocysts.
Methods: In a retrospective analysis, three hundred and forty PGT-A cycles are divided into study groups according to semen quality. Cycles were initially divided into two groups, discerning couples with absence of male factor of infertility (non-male factor: NMF; N = 146 cycles) from couples with a male factor of infertility (MF; N = 173 cycles).
Adv Exp Med Biol
September 2019
9.baby Family and Fertility Center, Bologna, Italy.
In the female reproductive tract, male gametes undergo a natural sperm selection process in order to discriminate spermatozoa on the basis of their quality to maximize the chances of successful reproduction. With the introduction of assisted reproductive technology (ART), scientists and clinicians developed diverse sperm selection strategies focusing on the isolation of competent spermatozoa. With increasing understanding of sperm functions and fertilization mechanism and evolution of available technologies, the initial simple sperm preparation protocols were complemented, and sometimes replaced, by new sperm-sorting techniques.
View Article and Find Full Text PDFMethods Mol Biol
May 2017
9. baby Family and Fertility Center, Via Dante 15, Bologna, I-40125, Italy.
Cryopreservation of human oocytes is an important technique for the treatment of human infertility, as it deals successfully with legal, ethical, and moral issues related to embryo cryopreservation (Coticchio et al., Human Fertil (Camb) 4:152-157, 2001; Tucker et al., Eur J Obstet Gynecol Reprod Biol 113: 524-527, 2004) and maintains reproductive potential in women with diseases or conditions that may compromise reproductive capacity.
View Article and Find Full Text PDF